Update: Capecitabine Warnings from NHS England

Both Macmillan (regimen patient information sheets) and CRUK (regimen specific consent forms) are updating their capecitabine containing documents to reference the warnings on Toxic Epidermal Necrolysis (TEN) and Stevens Johnson Syndrome(SJS)’ that NHS England commissioners have asked all providers (England) to ensure are made known to patients.   The updates to these documents will make it much easier for chemotherapy services to reply.   The updated documents should be available in next couple of weeks.

Thanks to all who have been involved in the speedy response.    

Latest News

By BOPA Research committee on 26th June 2025

SURVEY deadline extended – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…

Read article
By BOPA Committee on 26th June 2025

“Cancer Basics” videos by Elaine Vickers available free on Youtube

Elaine Vickers, PhD, creator of the UTIC course, has also produced a playlist of ten short videos on “Cancer Basics”, which is freely available on YouTube. In these videos, Elaine…

Read article
By BOPA Committee on 25th June 2025

🌟 Internship Opportunity with the British Oncology Pharmacy Association (BOPA) 🌟 

🌟 Internship Opportunity with the British Oncology Pharmacy Association (BOPA) 🌟  Are you passionate about cancer pharmacy and eager to make a meaningful impact in cancer care? The British Oncology…

Read article
By BOPA Executive Committee on 23rd June 2025

Meet the Board Members Webinars – Hosted by the UK Pharmacy Professional Leadership Advisory Board

The UK Pharmacy Professional Leadership Advisory Board (UKPPLAB) is leading development of a collaborative, inclusive, and effective model of pharmacy professional leadership (PPL) across the UK. Eight UK PPL organisations have…

Read article